Pharmacy- Page 43

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Biogen And AbbVie’s Once-Monthly ZINBRYTA Approved In EU To Treat MS

The FINANCIAL -- The European Commission (EC) has granted marketing authorization for ZINBRYTA (daclizumab) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), Biogen and AbbVie announced on July 5. ZINBRYTA is a once-monthly, self-administered, subcutaneous injection.

by The FINANCIAL

July 5, 2016

3 mins read

Pharmacy

Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals

The FINANCIAL -- Bristol-Myers Squibb Company and Cormorant Pharmaceuticals announced on July 5 that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant, a private, Stockholm, Sweden-based pharmaceutical company focused on the development of therapies for cancer and rare

by The FINANCIAL

July 5, 2016

1 min read

Pharmacy

Novo Nordisk invests DKK 400 million in an expanded production plant in Kalundborg

The FINANCIAL -- Novo Nordisk is investing 400 million Danish kroner in a 500 m2 extension of the world's largest insulin production plant in Kalundborg.

by The FINANCIAL

July 5, 2016

1 min read

Pharmacy

Takeda and TiGenix Enter into Licensing Agreement

The FINANCIAL -- Takeda Pharmaceutical Company Limited and TiGenix NV on July 5 announced that the companies have entered into an exclusive ex-U.S. license, development and commercialization agreement for Cx601, a suspension of allogeneic adipose-derived stem cells (eASC) injected intra-lesionally for the

by The FINANCIAL

July 5, 2016

1 min read

Pharmacy

Sanofi and Regeneron Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in Japan

The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the Ministry of Health, Labor and Welfare in Japan has granted marketing and manufacturing authorization for Praluent (alirocumab) for the treatment of uncontrolled low-density lipoprotein (LDL) cholesterol, in certain adult patients

by The FINANCIAL

July 5, 2016

2 mins read

Pharmacy

UCB and Daiichi Sankyo will jointly commercialize lacosamide in Japan

The FINANCIAL -- Daiichi Sankyo Company, Limited and UCB Biopharma SPRL ("UCB") on July 4 announced the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted approval for lacosamide (brand name VIMPAT) as an adjunctive therapy in the treatment of partial

by The FINANCIAL

July 4, 2016

1 min read

Pharmacy

European Commission Approves Extended Indication For Amgen’s Kyprolis (Carfilzomib)

The FINANCIAL -- Amgen on July 4 announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least

by The FINANCIAL

July 4, 2016

1 min read

Pharmacy

Takeda to Partner with Altos Therapeutics to Develop Promising Compound for the Treatment of Gastroparesis

The FINANCIAL -- Takeda Pharmaceutical Company Limited and Altos Therapeutics LLC on July 4 jointly announced the companies have entered into a definitive agreement to further the development of Altos’s proprietary compound ATC-1906.

by The FINANCIAL

July 4, 2016

1 min read

Pharmacy

Murdo Gordon Appointed Executive Vice President and Chief Commercial Officer

The FINANCIAL -- Bristol-Myers Squibb Company on June 20 announced that Murdo Gordon has been appointed executive vice president and chief commercial officer, a newly created position, effective June 21, 2016.

by The FINANCIAL

June 21, 2016

1 min read

Pharmacy

GSK: Executive Director Change

The FINANCIAL -- GSK on June 14 announces that Dr Moncef Slaoui, Chairman, Vaccines, has indicated to the Board his intention to retire from the Company in 2017. The Board supports Dr Slaoui’s decision and has agreed he will retire on 30

by The FINANCIAL

June 15, 2016

1 min read